Functionalized lipid nanocarriers for simultaneous delivery of docetaxel and tariquidar to chemoresistant cancer cells

HIGHLIGHTS

  • who: Chang Hyun Kim and collaborators from the College of Pharmacy, Chung-Ang University, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea have published the article: Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells, in the Journal: Pharmaceuticals 2023, 349 of 20/02/2023
  • what: The authors evaluated whether the simultaneous delivery of DTX and TRQ using a PRN (single-type nanocarrier) would increase the therapeutic efficacy of DTX by reversing the MDR effect in drug-resistant breast cancer cells as compared with delivery using dualtype nanocarriers.
  •  

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?